The first interest in the role of Glo1 in PCa dates back to the 1990s, when Ayoub et al. [105] and Di Ilio et al. [106] measured Glo1 specific activity in human tumor cell lines in vitro or cancerous and non-cancerous tissues. Here, GLO1 is linked to posterior cortical atrophy.